(Q51558354)

7 April 2018

title

Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control. (English)

1 reference

7 April 2018

0 references

Sözmen B

1

1 reference

7 April 2018

Delen Y

series ordinal

2

1 reference

7 April 2018

Girgin FK

series ordinal

3

1 reference

7 April 2018

Sözmen EY

series ordinal

4

1 reference

7 April 2018

publication date

1 August 1999

1 reference

7 April 2018

published in

Clinical Biochemistry

1 reference

7 April 2018

volume

32

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

423-427

1 reference

7 April 2018

Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Effect of N-DicyclopropylmethyI-amino-2-oxazoline (S-3341) on Antioxidant Status and Nitric Oxide in Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Does superoxide underlie the pathogenesis of hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

A simple method for determination of serum catalase activity and revision of reference range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

The biochemistry of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900034-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(99)00034-X

1 reference

7 April 2018

1 reference

7 April 2018